ArticleBMC neurology2025
Parkinson's disease: an integrative bioinformatics and machine learning analysis reveals tryptophan metabolism-associated gene biomarkers.
Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundParkinson’s disease (PD) represents a prevalent neurodegenerative disorder among the aging population, characterized by significant disruptions in neurological metabolic pathways. Recent evidence highlights the crucial role of tryptophan metabolism in the pathogenesis of PD; however, a comprehensive exploration of tryptophan metabolism genes (TMGs) and their specific contributions remains largely uncharted.
methodsEmploying bioinformatics, this study aimed to identify and validate TMGs associated with PD. A differential expression analysis was performed on a carefully selected set of four candidate genes. GSEA and GSVA were utilized to elucidate the biological functions and pathways linked to these TMGs. Additionally, Lasso regression and SVM-RFE were implemented to identify key hub genes and assess the diagnostic potential of three TMGs in distinguishing PD from non-PD samples. The relationship between critical TMGs and clinical parameters was also investigated, with expression validation conducted using datasets GSE6613 and GSE7621.
resultsOur analysis identified three TMGs—ALDH9A1, CYP1A1, and CYP1B1—as significantly associated with PD. These genes are implicated in essential biological processes, including the catabolism of small molecules, fatty acid metabolism, and alcohol metabolism, highlighting their extensive functional relevance in PD. Moreover, the diagnostic efficacy of these TMGs in differentiating PD from control samples showed promising results.
conclusionsThis study identifies three TMGs with substantial associations to PD, enhancing our molecular understanding of the disease. These findings not only contribute to the elucidation of PD at the molecular level but also pave the way for the development of novel biomarkers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.